SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

21626 reported adverse events

Drug classes: Dipeptidyl Peptidase 4 Inhibitor [EPC]

These side effects are most commonly reported by patients taking SITAGLIPTIN AND METFORMIN HYDROCHLORIDE:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 1511
1 DIARRHOEA 1398
2 NAUSEA 1111
3 DRUG INEFFECTIVE 1008
4 FATIGUE 902
5 ACUTE KIDNEY INJURY 838
6 VOMITING 781
7 WEIGHT DECREASED 718
8 DIZZINESS 639
9 PANCREATITIS 626
See all common reactions for SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADENOCARCINOMA PANCREAS 104 0.0809
1 PANCREATIC CARCINOMA METASTATIC 212 0.0745
2 DIABETES MELLITUS INADEQUATE CONTROL 423 0.0239
3 PANCREATIC CARCINOMA 588 0.0203
4 LACTIC ACIDOSIS 566 0.0175
5 MEDICATION RESIDUE PRESENT 70 0.0147
6 BLOOD GLUCOSE ABNORMAL 256 0.0138
7 DIABETIC NEUROPATHY 66 0.0133
8 GLYCOSYLATED HAEMOGLOBIN INCREASED 311 0.0123
9 LIPASE INCREASED 91 0.0119
See all enriched reactions for SITAGLIPTIN AND METFORMIN HYDROCHLORIDE